The Opioid Reckoning (Part 1): Paul Farrell Jr.

The Opioid Reckoning (Part 1): Paul Farrell Jr. on Litigation, Accountability, and the System That Failed

West Virginia has had the highest drug overdose death rate in the United States for over a decade. In a state with fewer than 2 million people, 780 million prescription opioids were distributed in just six years.

For Paul Farrell Jr., a Huntington, West Virginia native and mass tort attorney, those numbers weren’t abstract statistics. They were neighbors. Friends. Family members.

In Part 1 of this two-part episode, hosts Na-Ri Oh and Ian Wendt sit down with Paul to unpack how the largest civil litigation in American history — the opioid multidistrict litigation (MDL 2804) — came together, and how it reshaped the conversation around corporate accountability in the pharmaceutical supply chain.

This is not just a legal story. It’s a story about systems failure — across manufacturers, distributors, regulators, policymakers, and healthcare stakeholders — and what happens when transparency finally forces a reckoning.

• Growing up in Huntington, WV as the opioid crisis escalated

• The investigative journalism that exposed 780 million pills — and the moment Paul decided to act

• What “public nuisance” law is — and why it became the legal breakthrough strategy

• The role of distributors as the “choke point” in the opioid supply chain

• How 3,000+ cases consolidated into the largest MDL in U.S. history

• Why abatement — not just financial damages — became central to the settlement strategy

• Internal company communications that revealed troubling attitudes toward affected communities

• The intersection of regulation, enforcement, and corporate responsibility

• How transparency and subpoena power changed the trajectory of the crisis

For those working in pharma, healthcare, commercialization, policy, compliance, or distribution, this episode challenges us to examine difficult questions:

• Where does responsibility truly lie in a complex healthcare ecosystem?

• What happens when financial incentives distort oversight?

• And how do we prevent the next Pandora’s box from opening?

This episode sets the foundation for a deeper conversation about accountability, culture, regulation, and reform.

There was simply too much to cover in one episode.

In Part 2, we’ll explore:

• The evolution of the litigation and key tipping points

• The role of state attorneys general and settlement frameworks

• The ongoing PBM litigation

• The documentary The Bitter Pill

• And what lasting change should look like for the industry

Make sure to subscribe so you don’t miss it.